| Views | |
|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 171 |
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 10 | 6 | 8 | 4 | 13 | 13 | 18 |
| Views | |
|---|---|
| Pokrovskiy_Safety_21.pdf | 53 |
| Views | |
|---|---|
| United States | 60 |
| Canada | 21 |
| Germany | 6 |
| United Kingdom | 5 |
| Brazil | 4 |
| Russia | 4 |
| Australia | 3 |
| India | 3 |
| Mongolia | 3 |
| China | 2 |
| Views | |
|---|---|
| Ottawa | 18 |
| Mountain View | 11 |
| Houston | 9 |
| Englewood | 5 |
| San Francisco | 5 |
| Seattle | 3 |
| Ulaanbaatar | 3 |
| Dearborn | 2 |
| Nanterre | 2 |
| Voronezh | 2 |